Racial Disparities in Hospitalization Rates During Long-Term Follow-Up After Deceased-Donor Kidney Transplantation

被引:0
|
作者
Islam, Shahidul [1 ,2 ]
Zhang, Donglan [1 ,2 ]
Ho, Kimberly [2 ]
Divers, Jasmin [1 ,2 ]
机构
[1] NYU, Dept Fdn Med, Div Hlth Serv Res, Grossman Long Isl Sch Med, 101 Mineola Blvd, Mineola, NY 11501 USA
[2] NYU, Grossman Long Isl Sch Med, Mineola, NY 10016 USA
关键词
Racial disparities; Social determinants of health; Social Deprivation Index (SDI); Deceased-donor kidney transplant; Hospitalizations; HEALTH-CARE ACCESS; SOCIAL DETERMINANTS; ETHNIC DISPARITIES; HEART-FAILURE; ALLOGRAFT SURVIVAL; GRAFT LOSS; RACE; OUTCOMES; READMISSION; MORTALITY;
D O I
10.1007/s40615-023-01847-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
ObjectiveTo compare hospitalization rates between African American (AA) and European American (EA) deceased-donor (DD) kidney transplant (KT) recipients during over a10-year period.MethodData from the Scientific Registry of Transplant Recipients and social determinants of health (SDoH), measured by the Social Deprivation Index, were used. Hospitalization rates were estimated for kidney recipients from AA and EA DDs who had one kidney transplanted into an AA and one into an EA, leading to four donor/recipient pairs (DRPs): AA/AA, AA/EA, EA/AA, and EA/EA. Poisson-Gamma models were fitted to assess post-transplant hospitalizations.ResultUnadjusted hospitalization rates (95% confidence interval) were higher among all DRP involving AA, 131.1 (122.5, 140.3), 134.8 (126.3, 143.8), and 102.4 (98.9, 106.0) for AA/AA, AA/EA, and EA/AA, respectively, compared to 97.1 (93.7, 100.6) per 1000 post-transplant person-years for EA/EA pairs. Multivariable analysis showed u-shaped relationships across SDoH levels within each DRP, but findings varied depending on recipients' race, i.e., AA recipients in areas with the worst SDoH had higher hospitalization rates. However, EA recipients in areas with the best SDoH had higher hospitalization rates than their counterparts.ConclusionsRelationship between healthcare utilization and SDoH depends on DRP, with higher hospitalization rates among AA recipients living in areas with the worst SDoH and among EA recipients in areas with the best SDoH profiles. SDoH plays an important role in driving disparities in hospitalizations after kidney transplantation.
引用
收藏
页码:32 / 40
页数:9
相关论文
共 50 条
  • [1] Deceased-donor kidney transplantation: improvement in long-term survival
    Serur, David
    Saal, Stuart
    Wang, John
    Sullivan, John
    Bologa, Roxana
    Hartono, Choli
    Dadhania, Darshana
    Lee, Jun
    Gerber, Linda M.
    Goldstein, Michael
    Kapur, Sandip
    Stubenbord, William
    Belenkaya, Rimma
    Marin, Marina
    Seshan, Surya
    Ni, Quanhong
    Levine, Daniel
    Parker, Thomas
    Stenzel, Kurt
    Smith, Barry
    Riggio, Robert
    Cheigh, Jhoong
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (01) : 317 - 324
  • [2] Long-term Follow-up of Living-Donor Kidney Transplantation after Cadaveric Lung Transplantation
    Shiotani, Toshio
    Sugimoto, Seiichiro
    Araki, Kota
    Tomioka, Yasuaki
    Miyoshi, Kentaroh
    Otani, Shinji
    Yamane, Masaomi
    Toyooka, Shinichi
    ACTA MEDICA OKAYAMA, 2021, 75 (01) : 87 - 89
  • [3] Effect of Prediabetes on Allograft Survival and Evolution of New-Onset Diabetes After Transplant in Deceased-Donor Kidney Transplant Recipients During Long-Term Follow-Up
    Tillmann, Frank Peter
    Radtke, Amira
    Rump, Lars Christian
    Quack, Ivo
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2017, 15 (06) : 620 - 626
  • [4] Long-Term Kidney Transplant Survival after Deceased-Donor Acute Kidney Injury.
    Hall, I.
    Akalin, E.
    Bromberg, J.
    Doshi, M.
    Harhay, M.
    Jia, Y.
    Mansour, S.
    Mohan, S.
    Muthumkumar, T.
    Reese, P.
    Schroppel, B.
    Singh, P.
    Thiessen-Philbrook, H.
    Weng, F.
    Parikh, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 369 - 369
  • [5] How does alemtuzumab affect long-term graft and patient outcomes after deceased-donor kidney transplantation?
    Stuart J Knechtle
    Nature Clinical Practice Nephrology, 2005, 1 : 74 - 75
  • [6] How does alemtuzumab affect long-term graft and patient outcomes after deceased-donor kidney transplantation?
    Knechtle, SJ
    Owen, RD
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2005, 1 (02): : 74 - 75
  • [7] Long-term outcome of recipients with suboptimal graft function at 1 month after deceased-donor kidney transplantation
    Kim, Mihyeong
    Cho, Hyungjin
    Jang, Eunju
    Jun, Kangwoong
    Hwang, Jeongkye
    Park, Suncheol
    Kim, Jiil
    Yoon, Sangseop
    TRANSPLANTATION, 2024, 108 (9S)
  • [8] Long-term outcome of recipients with suboptimal graft function at 1 month after deceased-donor kidney transplantation
    Kim, Mihyeong
    Cho, Hyungjin
    Jang, Eunju
    Jun, Kangwoong
    Hwang, Jeongkye
    Park, Suncheol
    Kim, Jiil
    Yoon, Sangseop
    TRANSPLANTATION, 2024, 108 (09) : 333 - 333
  • [9] CARDIOVASCULAR LONG-TERM FOLLOW-UP AFTER PEDIATRIC KIDNEY TRANSPLANTATION
    Vial, R.
    Garaix, F.
    Tsimaratos, M.
    Burtey, S.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 22 - 22
  • [10] Racial Disparities in Oncologic Outcomes After Radical Prostatectomy: Long-term Follow-up
    Faisal, Farzana A.
    Sundi, Debasish
    Cooper, John L.
    Humphreys, Elizabeth B.
    Partin, Alan W.
    Han, Misop
    Ross, Ashley E.
    Schaeffer, Edward M.
    UROLOGY, 2014, 84 (06) : 1434 - 1441